Funding for this research was provided by:
State Administration of Traditional Chinese Medicine (TDZX2015200)
Received: 11 July 2018
Accepted: 23 November 2018
First Online: 3 January 2019
Ethics approval and consent to participate
: The trial has been approved by the Institutional Ethics Committee of GPHCM (B2016–097-01). Any protocol amendments must be reported to the Department of Science Research of GPHCM and agreed by the ethics committee. Each participant will receive information on this research, including the potential benefits and risks. The investigators must obtain informed consent from a patient before they are randomized. The personal information of the enrolled participants will be kept confidential. Only relevant investigators can access this information.
: Only anonymized data obtained in the observational study will be reported. Informed consent has been obtained from the patients for publication.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.